Health

AbbVie Receives FDA Approval for Parkinson’s Drug

Updated 2026-09-28 13:55 UTC 1 source Positive

The FDA has approved AbbVie's once-daily Parkinson's pill, based on a late-stage study that showed the drug helped improve symptoms.

Coverage timeline — 1 article
STAT News
The FDA has approved AbbVie’s once-daily Parkinson’s pill for sales, based on a late-stage study that showed the drug helped improve symptoms.
2026-09-28 13:40 UTC
Share: Twitter / X LinkedIn